KRAS-话题@MedSci

#KRAS#

77篇内容 | 2118人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1368977, encodeId=96ef13689e7d8, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=JCO：不推荐以KRAS状态作为NSCLC患者接受辅助化疗的标准, objectType=article, longId=17951, objectId=ce181e951cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce181e951cf, replyNumber=0, likeNumber=27, createdTime=2013-05-08, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce181e951cf, moduleTitle=JCO：不推荐以KRAS状态作为NSCLC患者接受辅助化疗的标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce181e951cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368976, encodeId=9c1713689e6cd, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=LANCET ONCOL :Selumetinib与多西他赛联合治疗KRAS基因突变晚期NSCLC疗效佳, objectType=article, longId=12811, objectId=3d99128118f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d99128118f, replyNumber=0, likeNumber=29, createdTime=2012-12-12, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d99128118f, moduleTitle=LANCET ONCOL :Selumetinib与多西他赛联合治疗KRAS基因突变晚期NSCLC疗效佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d99128118f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368975, encodeId=1b2313689e5dd, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, objectType=article, longId=8408, objectId=3968840823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3968840823, replyNumber=0, likeNumber=49, createdTime=2012-08-02, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3968840823, moduleTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3968840823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368974, encodeId=647313689e4ad, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=Br J Cancer: HRMA识别KRAS突变优于直接测序, objectType=article, longId=8095, objectId=85ef80953c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85ef80953c, replyNumber=0, likeNumber=57, createdTime=2012-07-25, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85ef80953c, moduleTitle=Br J Cancer: HRMA识别KRAS突变优于直接测序, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85ef80953c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368973, encodeId=63ee13689e344, content=<a href='/topic/show?id=13cb1056e20' target=_blank style='color:#2F92EE;'>#KRAS#</a>, objectTitle=美批准确定癌症患者KRAS突变的新检测法, objectType=article, longId=7726, objectId=8163e726a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8163e726a0, replyNumber=0, likeNumber=40, createdTime=2012-07-11, rootId=0, userName=yinhl1978, userId=8217292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8163e726a0, moduleTitle=美批准确定癌症患者KRAS突变的新检测法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8163e726a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

KRAS

2020-05-29

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

JCO：不推荐以KRAS状态作为NSCLC患者接受辅助化疗的标准

2013-05-08

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

LANCET ONCOL :Selumetinib与多西他赛联合治疗KRAS基因突变晚期NSCLC疗效佳

2012-12-12

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联

2012-08-02

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

Br J Cancer: HRMA识别KRAS突变优于直接测序

2012-07-25

yinhl1978 (审核中...)

前往app查看评论内容

#KRAS#

美批准确定癌症患者KRAS突变的新检测法

2012-07-11

科室
- - 订阅+
  - 更多科室
工具
服务